Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hepatocyte plasma membrane lipids constitute the structural and functional boundary of liver cells, primarily composed of phospholipids, cholesterol, and sphingolipids (Journal of Lipid Research, 2021). These lipids are not merely structural; they play a critical role in regulating membrane fluidity, signal transduction, and the activity of membrane-bound proteins such as transporters and receptors (StatPearls, 2023). In various liver diseases, including non-alcoholic steatohepatitis (NASH) and cholestasis, the composition and integrity of these lipids are often compromised, leading to cellular dysfunction and apoptosis (Journal of Clinical and Experimental Hepatology, 2016). Therapeutic strategies targeting these lipids involve the use of membrane-stabilizing agents like ursodeoxycholic acid or synthetic lipid conjugates like Aramchol, which aim to restore membrane homeostasis and modulate lipid metabolism (Galmed Pharmaceuticals, 2023). By altering the biophysical properties of the hepatocyte membrane, these drugs can mitigate the progression of liver fibrosis and inflammation. Furthermore, the lipid composition of the hepatocyte membrane is a key factor in the entry of hepatotropic viruses, making it a target for antiviral research (PubMed, 2022).
Modulation of membrane fluidity and stabilization of the lipid bilayer to prevent cellular damage and regulate lipid metabolism (StatPearls, 2023; Galmed Pharmaceuticals, 2023).
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hepatocyte plasma membrane lipids.